Search research articles

Search research articles

Related Experiment Videos

Current challenges in antibiotic resistance.

¹Departments of Research Development and Medicine, Texas Tech University Health Sciences Center-El Paso, El Paso, Texas 79905, USA.

Adolescent Medicine (Philadelphia, Pa.)

|August 1, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characteristics and mechanisms of azithromycin accumulation and efflux in human polymorphonuclear leukocytes.

International journal of antimicrobial agents·2001

Same author

Influence of pentoxifylline and its derivatives on antibiotic uptake and superoxide generation by human phagocytic cells.

Antimicrobial agents and chemotherapy·1995

Same author

Interactions of dirithromycin with human polymorphonuclear leukocytes.

Antimicrobial agents and chemotherapy·1993

Same author

Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase. Inhibition by phosphatidic acid phosphohydrolase inhibitors.

Journal of immunology (Baltimore, Md. : 1950)·1992

Same author

Uptake of antibiotics by human polymorphonuclear leukocyte cytoplasts.

Antimicrobial agents and chemotherapy·1990

Same author

Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes.

Antimicrobial agents and chemotherapy·1990

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

The rise in bacterial antibiotic resistance, particularly in common pathogens like Streptococcus pneumoniae and Staphylococcus aureus, poses a significant global health threat. This antimicrobial resistance complicates infection treatment and is largely driven by extensive antibiotic use.

Area of Science:

Microbiology
Infectious Diseases
Pharmacology

Background:

Antibiotic resistance in bacteria is a growing global concern, especially among common gram-positive coccal pathogens.
Key resistant organisms include penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant Enterococcus, and methicillin-resistant Staphylococcus aureus, all exhibiting multidrug resistance.
Resistance mechanisms involve altered cell wall-binding sites (beta-lactam and vancomycin resistance) and extended-spectrum beta-lactamase production in gram-negative bacilli.

Purpose of the Study:

To discuss the mechanisms, epidemiology, clinical importance, treatment, and prevention of antibiotic resistance.
To highlight the challenges posed by multidrug-resistant gram-positive cocci and gram-negative bacilli to antimicrobial therapy.
To identify the extensive and inappropriate use of antibiotics as the primary driver of emerging antimicrobial resistance.

Related Experiment Videos

Main Methods:

Review and synthesis of existing literature on antibiotic resistance mechanisms.
Epidemiological analysis of the spread of resistant bacterial strains.
Discussion of clinical implications and therapeutic strategies for managing resistant infections.

Main Results:

Antibiotic resistance in common pathogens significantly complicates or prevents effective antimicrobial treatment.
Altered cell wall-binding sites and beta-lactamase production are key resistance mechanisms.
Extensive and inappropriate antibiotic usage worldwide is the principal factor driving the emergence and dissemination of resistance.

Conclusions:

The increasing prevalence of antibiotic resistance necessitates a comprehensive approach to treatment and prevention.
Understanding microbial resistance mechanisms is crucial for developing new therapeutic strategies.
Global efforts to curb inappropriate antibiotic use are essential to mitigate the threat of antimicrobial resistance.